News
Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...
How does it work? What benefits does it offer? What risks does its use hide? Is there a legal option with corresponding training benefits?
17h
Verywell Health on MSN9 Medication Options for Managing Kidney DiseaseExplore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...
22h
News-Medical.Net on MSNNew Canadian guidelines offer comprehensive approach to managing pediatric obesitySurgical interventions can also be used to manage obesity among children. Laparoscopic sleeve gastrectomy or Roux-en-Y ...
New drug shows impressive results against lipoprotein(a), a genetic form of cholesterol that affects millions but remains ...
An investigational PCSK9 inhibitor with a different mechanism from existing drugs in this class has been shown to safely and ...
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...
One in four patients who present with elevated low-density lipoprotein cholesterol levels have no documented use of statin therapy, according to a study published April 16 in Epic Research. Here are ...
Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in ...
A new systematic review identifies 17 modifiable risk factors shared by stroke, dementia, and late-life depression — offering ...
Merck signs deal with Austria's Cyprumed to develop oral peptide therapies, potentially paying up to $493 million for access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results